Stocks Health care AZTR
NYSE · Health careAzitra, Inc. (AZTR)
It posted a net loss of $12.3M. In fiscal 2025 capital spending exceeded operating cash flow by $11.2M. At June 30, 2026 it held $6.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
What Azitra, Inc. does
Azitra, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker AZTR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$11M | -$2.25 | -$11.2M |
| 2024 | $7.5K | -$9M | -$15.70 | -$10.2M |
| 2023 | $686K | -$11.3M | -$364.21 | -$7.4M |
| 2023 | $284K | -$10.7M | -$2,535.56 | -$8.4M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Azitra, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026
- August 21, 2026Other event 8-K
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 12, 2026
- August 12, 2026
- July 15, 2026Other event 8-K
- June 25, 2026Passive stake (5% or more) SCHEDULE 13G
- June 24, 2026Activist stake (5% or more) SCHEDULE 13D
- June 22, 2026Passive stake (5% or more) SCHEDULE 13G
Insider trades
What the people running Azitra, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 16, 2026 | Salva Francisco D.President and CEO, Director | Exercised options | 4,064,050 | - |
Who owns AZTR
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Nantahala Capital Management, LLC13G, passive with 2 related filers | 9.99% | August 14, 2026 |
| Salva Francisco D.13D, may seek influence | 9.99% | June 24, 2026 |
| Stonepine Capital Management, LLC13G, passive with 3 related filers | 9.9% | June 22, 2026 |
| Dauntless Investment Group, LLC13G, passive | 9.6% | June 25, 2026 |
| Nantahala Capital Partners Limited Partnership13G, passive | 8.4% | August 14, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 4,086,291 shares in total, about $686.5K at the last price.
| Holder | Shares |
|---|---|
| Salva Francisco D.President and CEO, Director | 4,086,291 |
Questions about AZTR
What does Azitra, Inc. do?
Azitra, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker AZTR.
Is Azitra, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $12.3M.
When did Azitra, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 8, 2026.
Similar companies
Compare AZTR with
Follow AZTR
Get an email when Azitra, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow AZTR: get an email when it filesWhere the numbers come from
Financial figures are the values Azitra, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.